Published on 21 Mar 2024 on Benzinga
Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving...
Shares of Taysha Gene Therapies, Inc. TSHA rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results.
The company reported fiscal year 2023 losses of 96 cents per share, compared to losses of $3.78 per share from the prior year. Taysha reported it had $143.9 million in cash and cash equivalents on Dec. 31, 2023.